Respiratory therapy leads to a better outcome
Maintaining consistent airway clearance is a critical concern for patients living with cystic fibrosis, bronchiectasis, spinal injury, neuromuscular disorders or chronic obstructive pulmonary disease (COPD), as well as those recovering from serious injury or illness.1,2 For highrisk individuals, inadequate airway clearance has been associated with decreased lung function, higher rates of respiratory infection, recurring episodes of respiratory inflammation and hospital readmissions.3
Hill-Rom's Respiratory Care products work to improve airway clearance and lung health in both the acute care setting or in the home. The MetaNeb® and Vest® Systems mobilize retained secretions in the lower airways while the VitalCough® System removes secretions from the upper airways.
Learn more about Hill-Rom's Respiratory Care products
1. Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliary clearance in
health and disease. Eur Respir J. 1999;13(5):1177−1188.
2. Anderson CA, Palmer CA, Ney AL, et al. Evaluation of the safety of high-frequency chest wall
oscillation (HFCWO) therapy in blunt thoracic trauma patients. J Trauma Manag Outcomes. 2008;2:8−14.
3. Braverman J. Maintaining healthy lungs: the role of airway clearance therapy. Exceptional Parent.